Thompson Siegel & Walmsley’s Ameresco AMRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,100
Closed -$18K 790
2019
Q3
$18K Hold
1,100
﹤0.01% 586
2019
Q2
$16K Buy
+1,100
New +$16.8K ﹤0.01% 602
2019
Q1
Sell
-1,100
Closed -$16K 665
2018
Q4
$16K Hold
1,100
﹤0.01% 593
2018
Q3
$15K Hold
1,100
﹤0.01% 638
2018
Q2
$13K Hold
1,100
﹤0.01% 670
2018
Q1
$14K Hold
1,100
﹤0.01% 654
2017
Q4
$9K Hold
1,100
﹤0.01% 722
2017
Q3
$9K Hold
1,100
﹤0.01% 714
2017
Q2
$8K Hold
1,100
﹤0.01% 715
2017
Q1
$7K Hold
1,100
﹤0.01% 719
2016
Q4
$6K Hold
1,100
﹤0.01% 670
2016
Q3
$6K Hold
1,100
﹤0.01% 666
2016
Q2
$5K Hold
1,100
﹤0.01% 675
2016
Q1
$5K Hold
1,100
﹤0.01% 641
2015
Q4
$7K Hold
1,100
﹤0.01% 627
2015
Q3
$6K Hold
1,100
﹤0.01% 644
2015
Q2
$8K Hold
1,100
﹤0.01% 628
2015
Q1
$8K Hold
1,100
﹤0.01% 636
2014
Q4
$8K Hold
1,100
﹤0.01% 641
2014
Q3
$8K Hold
1,100
﹤0.01% 634
2014
Q2
$8K Hold
1,100
﹤0.01% 610
2014
Q1
$8K Hold
1,100
﹤0.01% 602
2013
Q4
$11K Hold
1,100
﹤0.01% 567
2013
Q3
$11K Hold
1,100
﹤0.01% 563
2013
Q2
$10K Buy
+1,100
New +$8.78K ﹤0.01% 582

Other funds holding AMRC

Thompson Siegel & Walmsley's AMRC Position: Q4 2019 in Review

Thompson Siegel & Walmsley sold out of Ameresco (AMRC) in Q4 2019, closing a stake of 1,100 shares — an estimated $18K sold.

Thompson Siegel & Walmsley first reported a position in AMRC in Q2 2013 and held it in 25 quarters. The position peaked at $18K in Q3 2019. 97 funds tracked by Wall St. Rank hold AMRC as of Q4 2019.

  • Thompson Siegel & Walmsley reported no remaining Ameresco position as of Q4 2019 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 1,100 Ameresco shares in Q4 2019, an estimated $18K.
  • Thompson Siegel & Walmsley first reported a position in Ameresco in Q2 2013 and held it in 25 quarters.
  • Thompson Siegel & Walmsley's Ameresco position peaked at $18K in Q3 2019.
  • 97 funds tracked by Wall St. Rank held Ameresco as of Q4 2019.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2019, filed 7 Feb 2020.